What's new at Łukasiewicz – PORT?
- Reading time: 3 min.
With nearly PLN 2 million in new funding, Łukasiewicz – PORT will advance work on a photonic biosensor designed to support fast, sensitive diagnostics closer to the patient.
- Reading time: 3 min.
How does the nervous system integrate signals from the body and the outside world? In the next open seminar, Dr. Kuo-Sheng Lee will discuss how animals monitor both their environment and internal states.
- Reading time: 3 min.
With funding from the Ministry of Science and Higher Education, Dr. Paweł Sega is building the BioValid platform, which will enable the analysis of microorganisms at the single-cell level.
- Reading time: 3 min.
Dr. Krzysztof Czyż represented Łukasiewicz – PORT at the Photonics Partnership Annual Meeting in Brussels, a key European event on the future of photonics, with discussions covering technologies developed at the institute and solutions for modern diagnostics.
- Reading time: 3 min.
The Biobank Research Group has increased its biological sample collection by 500%, enabling the Population Diagnostics Center, led by Dr. hab. Patrycja Gazińska, to reach a key milestone in the P4Health project funded under Teaming for Excellence.
- Reading time: 3 min.
From May 18 to 21, 2027, Wrocław will host the 12th International γδ T Cell Conference, a leading global meeting for researchers studying γδ T cells – immune cells with tremendous therapeutic potential.
- Reading time: 3 min.
The Virtual Research Institute (WIB), operating within the structure of Łukasiewicz – PORT, is seeking partners for the commercialization of an innovative mRNA-based technology. The technology was developed by one of WIB’s research teams, and we are looking for a partner to help further develop and bring it to market.
- Reading time: 3 min.
“If I had to choose one word that is essential for the future of oncology, I would say: connections,” said Prof. Stefaan van Gool at PORT for Health: Oncology 2026. Participants agreed that the future lies in combination therapies, precision medicine, and close collaboration between research and clinical practice.
- Reading time: 3 min.
Prof. Bastian Hengerer, Director of the P4Health Center, talks about his vision for the center, translating scientific discoveries into solutions for patients, and management based on trust.
- Reading time: 5 min.
Glioblastoma is one of the most formidable challenges in modern oncology—a cancer that often evades both conventional treatments and advanced immunotherapies. In the SelCell project, scientists at the Łukasiewicz – PORT are exploring a new strategy based on gamma-delta T lymphocytes. Their goal is to understand why immune cells from some donors can destroy tumor cells far more effectively than those from others.
- Brak wpisów w kategorii